Journal of Medical Economics, Volume 17, Issue 12 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 17, Issue 12 (2014)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Volume 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Diabetes: Original article

Article
The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial
Rhodri Saunders, Jean Lian, Boris Karolicki & William Valentine
Pages: 827-836
Published online: 12 Sep 2014
AbstractforThe cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial | Full Text | References | PDF (408.9 KB)
  • 675 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Oncology: Original article

Article
Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe
Mario Campone, Hongbo Yang, Elizabeth Faust, Andrew Kageleiry, James E. Signorovitch, Jie Zhang & Haitao Gao
Pages: 837-845
Published online: 18 Sep 2014
AbstractforCost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe | Full Text | References | PDF (148.6 KB)
  • 1363 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular: Original article

Article
Right anterior thoracotomy aortic valve replacement is associated with less cost than sternotomy-based approaches: a multi-institution analysis of ‘real world’ data
Evelio Rodriguez, S. Chris Malaisrie, John R. Mehall, Matt Moore, Arash Salemi, Gorav Ailawadi, Candace Gunnarsson, Alison F. Ward, Eugene A. Grossi & on behalf of the Economic Workgroup on Valvular Surgery
Pages: 846-852
Published online: 19 Sep 2014
AbstractforRight anterior thoracotomy aortic valve replacement is associated with less cost than sternotomy-based approaches: a multi-institution analysis of ‘real world’ data | Full Text | References | PDF (245.5 KB) | Supplemental
  • 463 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Neurology: Original article

Article
Utility decrements associated with side effects in schizophrenia
A. Millier, I. Amri, L. Boyer, P. Auquier & M. Toumi
Pages: 853-861
Published online: 23 Sep 2014
AbstractforUtility decrements associated with side effects in schizophrenia | Full Text | References | PDF (107.3 KB)
  • 734 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Gastroenterology: Original articles

Article
Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost
Neeta Tandon, Luis A. Balart, François Laliberté, Dominic Pilon, Patrick Lefebvre, Guillaume Germain & Avinash Prabhakar
Pages: 862-871
Published online: 08 Oct 2014
AbstractforImpact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost | Full Text | References | PDF (174.1 KB)
  • 690 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Healthcare costs for Crohn’s disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence
Brian G. Feagan, Chris M. Kozma, Terra L. Slaton, William H. Olson & George J. Wan
Pages: 872-880
Published online: 27 Aug 2014
AbstractforHealthcare costs for Crohn’s disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence | Full Text | References | PDF (177.5 KB)
  • 716 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
How costly is non-adherence to infliximab in patients with Crohn’s disease?
Christian P. Selinger
Pages: 881-882
Published online: 26 Sep 2014
CitationforHow costly is non-adherence to infliximab in patients with Crohn’s disease? | Full Text | References | PDF (47.2 KB)
  • 690 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Professional: Brief report

Brief Report
Evolving provider payment models and patient access to innovative medical technology
Genia Long, Richard Mortimer & Geoffrey Sanzenbacher
Pages: 883-893
Published online: 08 Oct 2014
AbstractforEvolving provider payment models and patient access to innovative medical technology | Full Text | References | PDF (352.8 KB)
  • 838 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Impact of COVID-19 on work loss in the United States- A retrospective database analysis
Jennifer Judy et al.
Article | Published online: 18 Jul 2024
Open Access
Cost analysis of patiromer versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in Spain and the UK
Antonio Ramirez de Arellano et al.
Article | Published online: 18 Jul 2024
Open Access
The clinical and economic burdens of metabolic dysfunction-associated steatohepatitis
Michael Charlton et al.
Article | Published online: 17 Jul 2024
Open Access
Budget impact analysis of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma
Ivo Abraham et al.
Article | Published online: 17 Jul 2024
Open Access
View all latest articles